Ertapenem Injectable (IV/IM) bulk supplier for pharma manufacturers

Ertapenem Injectable (IV/IM) Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 1 g per vial for IV or IM use

Reference Brands: Invanz(US & EU)

Ertapenem inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis and death. Its broad-spectrum activity includes resistant gram-negative bacteria. Benefits include rapid bacterial clearance, high tissue penetration, once-daily dosing, and effectiveness against serious infections like intra-abdominal infections and pneumonia in hospital settings.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ertapenem Injectable (IV/IM)? List it or send an offer →

Product Description:

Ertapenem injectable is approved in the EU and US for treating complicated intra-abdominal infections, skin and soft tissue infections, and community-acquired pneumonia. In the EU, brands like Invanz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA-approved formulations are based on extensive clinical data; generic versions are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antibacterial therapy.

Ertapenem Injectable (IV/IM) — third party manufacturing & bulk supply

Ertapenem Injectable (IV/IM) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ertapenem Injectable (IV/IM) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ertapenem Injectable (IV/IM) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ertapenem Injectable (IV/IM) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ertapenem Injectable (IV/IM) is listed as Injectable (IV/IM) in 1 g per vial for IV or IM use. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ertapenem Injectable (IV/IM) is referenced against Invanz(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.